Epigenetic Profiling of CUP.
DNA methylation profiling may have potential in unmasking the origin of tumors classified as cancer of unknown primary. A diagnostic assay developed by the researchers, EPICUP, predicted the primary tumor site in 87% of 216 cases, and these predictions were subsequently verified through various tests, including immunohistochemistry.